Cathie Wood Crispr Therapeutics Ag Transaction History

Ark Investment Management LLC

  • $9.28 Billion
  • Q1 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ark Investment Management LLC holds 10,165,400 shares of CRSP stock, worth $611 Million. This represents 3.73% of its overall portfolio holdings.

Number of Shares
10,165,400
Previous 8,973,064 13.29%
Holding current value
$611 Million
Previous $353 Million 2.05%
% of portfolio
3.73%
Previous 3.09%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 07, 2025
BUY
$34.03 - $53.02 $40.6 Million - $63.2 Million
1,192,336 Added 13.29%
10,165,400 $346 Million
Q4 2024

Feb 04, 2025
BUY
$38.65 - $55.15 $57 Million - $81.3 Million
1,474,439 Added 19.66%
8,973,064 $353 Million
Q3 2024

Oct 31, 2024
SELL
$44.62 - $62.75 $12.5 Million - $17.6 Million
-279,911 Reduced 3.6%
7,498,625 $352 Million
Q2 2024

Jul 26, 2024
SELL
$51.17 - $68.18 $19.4 Million - $25.8 Million
-378,492 Reduced 4.64%
7,778,536 $420 Million
Q1 2024

Apr 18, 2024
SELL
$60.67 - $89.12 $23 Million - $33.8 Million
-379,076 Reduced 4.44%
8,157,028 $556 Million
Q4 2023

Jan 17, 2024
BUY
$38.62 - $72.18 $53 Million - $99.1 Million
1,372,986 Added 19.17%
8,536,104 $534 Million
Q3 2023

Oct 18, 2023
SELL
$45.39 - $59.0 $7.96 Million - $10.3 Million
-175,329 Reduced 2.39%
7,163,118 $325 Million
Q2 2023

Jul 10, 2023
SELL
$43.47 - $67.77 $28.3 Million - $44.2 Million
-651,741 Reduced 8.16%
7,338,447 $412 Million
Q1 2023

Apr 17, 2023
BUY
$41.0 - $56.12 $6.57 Million - $8.99 Million
160,256 Added 2.05%
7,990,188 $361 Million
Q4 2022

Jan 24, 2023
SELL
$39.19 - $65.67 $16 Million - $26.7 Million
-407,190 Reduced 4.94%
7,829,932 $0
Q3 2022

Oct 17, 2022
SELL
$61.1 - $83.78 $91.1 Million - $125 Million
-1,490,409 Reduced 15.32%
8,237,122 $538 Million
Q2 2022

Jul 11, 2022
BUY
$43.23 - $73.83 $14 Million - $23.9 Million
323,460 Added 3.44%
9,727,531 $565 Million
Q1 2022

Apr 19, 2022
BUY
$53.19 - $79.24 $16.8 Million - $25.1 Million
316,203 Added 3.48%
9,404,071 $590 Million
Q4 2021

Jan 28, 2022
BUY
$70.09 - $111.29 $105 Million - $167 Million
1,502,194 Added 19.8%
9,087,868 $689 Million
Q3 2021

Nov 12, 2021
SELL
$110.2 - $156.64 $21 Million - $29.8 Million
-190,445 Reduced 2.45%
7,585,674 $849 Million
Q2 2021

Aug 05, 2021
SELL
$100.84 - $161.89 $51.9 Million - $83.2 Million
-514,231 Reduced 6.2%
7,776,119 $1.26 Billion
Q1 2021

May 13, 2021
SELL
$110.72 - $210.04 $235 Million - $446 Million
-2,122,626 Reduced 20.38%
8,290,350 $1.01 Billion
Q4 2020

Feb 12, 2021
BUY
$79.67 - $173.23 $156 Million - $339 Million
1,955,656 Added 23.12%
10,412,976 $1.59 Billion
Q3 2020

Oct 30, 2020
BUY
$78.5 - $100.64 $155 Million - $199 Million
1,974,069 Added 30.45%
8,457,320 $707 Million
Q2 2020

Aug 11, 2020
BUY
$38.5 - $76.05 $84.6 Million - $167 Million
2,197,619 Added 51.28%
6,483,251 $476 Million
Q1 2020

May 14, 2020
BUY
$33.68 - $62.53 $44.8 Million - $83.1 Million
1,328,997 Added 44.95%
4,285,632 $182 Million
Q4 2019

Jan 31, 2020
BUY
$36.68 - $73.13 $6.4 Million - $12.8 Million
174,495 Added 6.27%
2,956,635 $180 Million
Q3 2019

Nov 12, 2019
BUY
$40.99 - $52.56 $2.37 Million - $3.04 Million
57,791 Added 2.12%
2,782,140 $114 Million
Q2 2019

Jul 30, 2019
BUY
$35.45 - $48.2 $24.9 Million - $33.8 Million
701,332 Added 34.67%
2,724,349 $128 Million
Q1 2019

May 13, 2019
BUY
$28.02 - $40.87 $19.6 Million - $28.5 Million
697,907 Added 52.67%
2,023,017 $72.3 Million
Q4 2018

Feb 01, 2019
SELL
$22.73 - $42.34 $2.92 Million - $5.44 Million
-128,480 Reduced 8.84%
1,325,110 $37.9 Million
Q3 2018

Nov 07, 2018
BUY
$44.35 - $65.71 $43.7 Million - $64.8 Million
986,450 Added 211.17%
1,453,590 $64.5 Million
Q2 2018

Aug 07, 2018
BUY
$42.62 - $73.59 $16.8 Million - $29 Million
394,606 Added 544.03%
467,140 $27.4 Million
Q1 2018

May 14, 2018
BUY
$23.52 - $58.17 $967,753 - $2.39 Million
41,146 Added 131.09%
72,534 $3.32 Million
Q4 2017

Feb 12, 2018
BUY
$16.95 - $23.48 $98,869 - $136,958
5,833 Added 22.83%
31,388 $737,000
Q3 2017

Nov 09, 2017
BUY
$16.75 - $20.66 $212,172 - $261,700
12,667 Added 98.29%
25,555 $457,000
Q2 2017

Aug 11, 2017
BUY
N/A
12,888
12,888 $206,000

Others Institutions Holding CRSP

# of Institutions
480
Shares Held
64.2M
Call Options Held
2.15M
Put Options Held
1.92M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $4.69B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track Cathie Wood's Portfolio

Track Cathie Wood Portfolio

Follow Cathie Wood (Ark Investment Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email